Evidence map›Paper›PMID 36401329›Full record

ArticleJournal of biomedical science2022

Interference in melanoma CD248 function reduces vascular mimicry and metastasis.

Cheng-Hsiang Kuo, Ya-Fang Wu, Bi-Ing Chang, Chao-Kai Hsu, Chao-Han Lai, Hua-Lin Wu

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Murine Cell Line Models for Vascular Mimicry: The Role of YAP/TAZ Signaling.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cheng-Hsiang KuoInternational Center for Wound Repair and Regeneration, National Cheng Kung University, Tainan, Taiwan. 10102080@gs.ncku.edu.tw.ORCID http://orcid.org/0000-0002-4885-9020
Ya-Fang WuDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, No. 1, University Road, 701, Tainan, Taiwan.
Bi-Ing ChangDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, No. 1, University Road, 701, Tainan, Taiwan.
Chao-Kai HsuInternational Center for Wound Repair and Regeneration, National Cheng Kung University, Tainan, Taiwan.
Chao-Han LaiDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, No. 1, University Road, 701, Tainan, Taiwan.
Hua-Lin WuDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, No. 1, University Road, 701, Tainan, Taiwan. halnwu@ncku.edu.tw.
National Cheng Kung University · TWNational Cheng Kung University Hospital · TW

Funding

Ministry of Science and Technology MOST-108-2320-B-006-014Ministry of Science and Technology MOST-109-2320-B-006-023Ministry of Science and Technology MOST-110-2320-B-006-051
6 · The paper itself

Abstract

backgroundTumor vascular mimicry is an emerging issue that affects patient survival while having no treatment at the current moment. Despite several factors implicated in vascular mimicry, little is known about stromal factors that modulate tumor microenvironment and shape malignant transformation. CD248, a type-I transmembrane protein dominantly expressed in stromal cells, mediates the interaction between cells and extracellular matrix proteins. CD248 protein expression is associated with the metastatic melanoma phenotype and promotes tumor progression in the stromal cells. This study aimed to explore the cell-autonomous effects of CD248 in melanoma vascular mimicry to aid cancer therapy development.

methodsLoss-of-function approaches in B16F10 melanoma cells were used to study the cell-autonomous effects of CD248 on cell adhesion, migration, proliferation, and vascular mimicry. A solid-phase binding assay was performed to identify the interaction between CD248 and fibronectin. Horizontal and vertical cell migration assays were performed to analyze cell migration activity, and cell-patterned network formation on Matrigel was used to evaluate vascular mimicry activity. Recombinant CD248 (rCD248) proteins were generated, and whether rCD248 interfered with melanoma CD248 functions was evaluated in vitro. An experimental lung metastasis mouse model was used to investigate the effect of rCD248 treatment in vivo.

resultsCD248 protein expression in melanoma cells was increased by a fibroblast-conditioned medium. Knockdown of CD248 expression significantly decreased cell adhesion to fibronectin, cell migration, and vascular mimicry in melanoma cells. The lectin domain of CD248 was directly involved in the interaction between CD248 and fibronectin. Furthermore, rCD248 proteins containing its lectin domain inhibited cell adhesion to fibronectin and slowed down cell migration and vascular mimicry. Treatment with rCD248 protein could reduce pulmonary tumor burden, accompanied by a reduction in vascular mimicry in mice with melanoma lung metastasis.

conclusionCD248 expression in melanoma cells promotes malignant transformation by increasing the activity of cell adhesion, migration, and vascular mimicry, whereas rCD248 protein functions as a molecular decoy interfering with tumor-promoting effects of CD248 in melanoma cells.

Indexed as

Lung NeoplasmsMelanomaAnimalsAntigens, CDAntigens, NeoplasmCell AdhesionFibronectinsLectinsMiceTumor MicroenvironmentAntigens, CDAntigens, NeoplasmCD248 protein, mouseFibronectinsLectinsCD248FibronectinMelanomaMetastasisVascular mimicry

Identifiers

PMID36401329
PMCPMC9673323
OpenAlexW4309561254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.